Biotechnology

Laurus Labs Ltd Q3FY24; 89% fall in Profits

● Feb 20, 2024

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active...

Syngene International Ltd Q3FY24; 2% rise in Profits

● Jan 25, 2024

Syngene (established in 1993) as a Biocon subsidiary is India’s first Contract Research Organization (CRO) which expanded later to be...

Laurus Labs Limited Q3 FY24 Earnings Conference Call Insights

● Jan 25, 2024

Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY24 Earnings Concall Business Performance Gross margins remained resilient at over 52%...

Laurus Labs Limited Q2 FY24 Earnings Conference Call Insights

● Oct 20, 2023

Key highlights from Laurus Labs Limited (LAURUSLABS) Q2 FY24 Earnings Concall Q2 FY24 Results Revenue declined 22% year-on-year to INR1,224...

Syngene International Ltd Q2FY24; 14% rise in Profits

● Oct 17, 2023

Syngene (established in 1993) as a Biocon subsidiary is India’s first Contract Research Organization (CRO) which expanded later to be...

Wockhardt Ltd Q1FY24; 8% rise in Revenue

● Aug 14, 2023

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams...

Shilpa Medicare Ltd Q1FY24; 50% fall in Profits

● Aug 10, 2023

Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system,...

Panacea Biotec Q4FY23 Earnings Story

● Jun 2, 2023

Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly...

Panacea Biotec Q4FY23; 8% Fall in Revenues

● May 31, 2023

Panacea Biotec Ltd.’s revenue in Q4FY23 rose 13% to ₹ 12,557 crores. Consolidated Profit After Tax came at ₹ 4,320...

Laurus Labs Limited Q4 FY23 Earnings Conference Call Insights

● Apr 28, 2023

Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Management Update: [00:09:24]LAURUSLABS said it invested in expanding non-ARV...